Laurus Labs Ltd (NSE:LAURUSLABS) Share Price

Company Profile

Business description
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.
Contact
Road No. 7, Banjara Hills
2nd Floor, Serene Chambers
HyderabadTG500034
IND
T: +91 4039804333
https://www.lauruslabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
12,467

Recommended

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.

Brian Han | 11 September 2025

Shares jumped in response to the latest results.

Luke Yang, CFA | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,128.70	18.10	0.20%
CAC 40	7,784.21	39.31	-0.50%
DAX 40	23,620.80	82.85	-0.35%
Dow JONES (US)	46,108.00	617.08	1.36%
FTSE 100	9,324.78	27.20	0.29%
HKSE	26,388.16	301.84	1.16%
NASDAQ	22,043.07	157.01	0.72%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,227.90	1.25	-0.01%
S&P 500	6,587.47	55.43	0.85%
S&P/ASX 200	8,864.90	22.00	0.25%
SSE Composite Index	3,870.60	4.71	-0.12%